For Women Only…

The Gender Retirement Gap Back in March of this year, we wrote about an interesting article penned by Diane Garnick. Diane is regarded as one of the brightest minds on Wall Street and currently works at one of the largest money managers in the world—TIAA where she is the Managing Director and Chief Income Strategist.…

0 comments

A Primer on Orphan Drugs

One of the most intriguing areas in today’s pharmaceutical sector is the topic of orphan drugs. Orphan drugs are drugs that are used to treat rare diseases – for example, Orkambi and Kalydeco, two drugs brought to market by Vertex Pharmaceuticals. Both drugs are highly effective in treating certain variants of Cystic Fibrosis, a rare…

0 comments

The Generational Test for Investing….

One of the simplest techniques to help determine investment merit was actually made by a co-worker of mine. A couple of colleagues and I were discussing investment styles and strategies that had served them well over the years. One was oriented to short-term speculation and trading, another had a longer-term perspective (that would be me).…

0 comments

Mental Accounting

As a publication dedicated to helping people meet investment goals through educated decision-making, In Sickness and Wealth is pleased to share this must-read article! I have had the honor and pleasure of knowing Diane Garnick for nearly 20 years now. Diane is Managing Director and Chief Income Strategist at TIAA. TIAA (Formerly TIAA-CREF – Teachers…

1 comment

The Ultimate Joint Venture Between Biz and Government

On December 13th, Obama signed into law the 21st Century Cures Act. It enacts significant investments for innovative technologies and research to positively impact patients… undoubtedly through some of the healthcare companies in our portfolio and the many others we follow as well. It represents the ultimate joint venture between academia and business, as educators…

0 comments